Fast growing commercial pharma organizations tend to look remarkably similar beneath the org chart. Brilliant people, deep in their specialties, moving quickly because the goal is clear, and the patients waiting are real. That speed is necessary. It also means plans are sometimes more directional than definitive, decisions ripple beyond the people in the room, and dependencies slip until they become urgent. That's where I tend to add the most value: connecting the work downstream, making the tradeoffs visible, and helping teams stay aligned as priorities shift. Alignment isn't a one time thing, it has a shelf life, and it's best kept fresh.
There will always be tension between moving quickly and moving intentionally. The answer isn't more process or more meetings. It's a small amount of discipline at the right moments: prepare stakeholders, clarify the objective, share context early, and record the decisions that matter. Those habits keep manageable tradeoffs from turning into burnout, fire drills, and meetings everyone wished was an email. Even the sharpest executive teams appreciate having them in place.
I've seen the same pattern across companies of every size, not because anyone dropped the ball, but because growth forces tradeoffs that no one has time to trace completely. A commercial team ships a target list under real deadline pressure. The content was approved by [PRC, LMR, whatever your TLA is], campaign timing is critical, and chasing down every team that might eventually depend on that decision is hard in the moment. Six weeks later the list resurfaces as a fire drill somewhere downstream, sometimes as a risk, sometimes as an issue. That wasn't a mistake. It was the tradeoff decision, now coming due.
The artifacts I build, a tracker, a scorecard, a decision log, a plan on a page, are simply ways to expose those tradeoffs before they become surprises. They help answer three practical questions: what brought us here, who's now depending on it, and what gets resolved now versus deliberately carried forward. I want to know who's seen a given risk, who owns mitigating it, and whether that's actually been said out loud. It's simple stuff. Most project managers worth their bill rate would raise it. Many don't, sometimes because they're too junior, sometimes because they're reluctant to stand against the momentum in the room, sometimes because they don't see the relationships in the bigger picture yet. The leaders driving these organizations are moving at the pace the mission demands. My role is narrower: build the map that lets them keep moving, while making the next tradeoff on purpose, in the open, instead of by accident.
Takeaway
The tracker, scorecard, or plan is rarely the important artifact. Any decent methodology calls these out, I've worked in most of them. The value is in making dependencies visible, tying decisions back to their purpose, and showing where yesterday's alignment needs revisiting. As an outside advisor, I get to ask the questions busy teams often don't have the space to ask: does this still line up with that other decision, or are we drifting? What about the person still delivering against the old decision, do they know it changed? What tradeoff actually brought us here? Do we address the consequence now, or plan for it later?